Diabetes mellitus and the incidence of colorectal cancer: An updated systematic review and meta-analysis

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1576-1585

  Deng, Longying ^a   Gui, Zhifu ^a   Zhao, Lianying ^b   Wang, Jianping ^a   Shen, Lizong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Diabetes mellitus; Meta analysis; Risk

Indexed keywords

INSULIN; METFORMIN;

BODY MASS; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; COHORT ANALYSIS; COLORECTAL CANCER; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; INSULIN TREATMENT; LONG TERM CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TOBACCO;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84864278884     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2055-1     Document Type: Review

References (47)

1. Omran S, Ismail AA. Knowledge and beliefs of Jordanians toward colorectal cancer screening. Cancer Nurs. 2010;33: 141-148.
2. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007;132:2208-2225. (Pubitemid 46693749)
3. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009;124:2406-2415.
4. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103-1123.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053. (Pubitemid 38579764)
6. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6:164-179.
7. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687-695. (Pubitemid 24377963)
8. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005; 97:1679-1687. (Pubitemid 41672234)
9. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007;16:83-89. (Pubitemid 46105011)
10. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871-1877. (Pubitemid 44455170)
11. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese health study. J Natl Cancer Inst. 2006;98:135-138. (Pubitemid 43159968)
12. Khan M, Mori M, Fujino Y, et al. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan collaborative cohort (JACC) Study. Asian Pac J Cancer Prev. 2006;7:253-259.
13. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics, 2007 fact sheet. Bethesda: US Department of Health and Human Services, National Institutes of Health; 2008.
14. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003;289: 2254-2264. (Pubitemid 37430194)
15. Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rect. 2008;51:593-597.
16. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 2004;127:1044-1050.
17. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52:1766-1777.
18. Campbell PT, Deka A, Jacobs EJ, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010;139: 1138-1146.
19. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Iniciativa STROBE: the strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Rev Esp Salud Publ. 2008;82:251-259.
20. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis. 1985;38:435-441. (Pubitemid 15025864)
21. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res. 1988;48: 4399-4404.
22. Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res. 1997;57:4787-4794. (Pubitemid 27468985)
23. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1997;6:1007-1010. (Pubitemid 28007409)
24. Levi F, Pasche C, Lucchini F, La Vecchia C. Diabetes mellitus, family history, and colorectal cancer. J Epidemiol Community Health. 2002;56:479-480. Author reply 480. (Pubitemid 34539008)
25. Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol. 2005;3:587-594. (Pubitemid 40824752)
26. Vinikoor LC, Long MD, Keku TO, Martin CF, Galanko JA, Sandler RS. The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev. 2009;18:1239-1242.
27. Steenland K, Nowlin S, Palu S. Cancer incidence in the national health and nutrition survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev. 1995;4:807-811.
28. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol. 1998;147:816-825. (Pubitemid 28244386)
29. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542-547. (Pubitemid 29157063)
30. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999;91:1147-1154. (Pubitemid 29330553)
31. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84: 417-422. (Pubitemid 32154439)
32. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer - Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004;13:915-919. (Pubitemid 38756700)
33. Limburg PJ, Anderson KE, Johnson TW, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev. 2005;14: 133-137. (Pubitemid 40165293)
34. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194-202. (Pubitemid 40095870)
35. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care. 2005;28:1805-1807. (Pubitemid 40923101)
36. Flood A, Strayer L, Schairer C, Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010;21:1277-1284.
37. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA. The association of diabetes with colorectal cancer risk: the multiethnic cohort. Br J Cancer. 2010;103:120-126.
38. Li C, Balluz LS, Ford ES, Okoro CA, Tsai J, Zhao G. Association between diagnosed diabetes and self-reported cancer among US adults. Diabetes Care. 2011;34:1365-1368.
39. Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One. 2011;6: e19930.
40. Levi Z, Kark JD, Barchana M, et al. Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer Epidemiol Biomarkers Prev. 2011; 20:2524-2531.
41. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60:207-221.
42. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131:3109S-3120S. (Pubitemid 33070788)
43. Le Roith D. Seminars in medicine of the Beth Israel deaconess medical center: insulin-like growth factors. N Engl J Med. 1997; 336:633-640.
44. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer. 1992;65:311-320.
45. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev. 1992;8:229-257.
46. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 2005;6:103-111. (Pubitemid 40197704)
47. Smith CJ, McKay GA, Fisher M. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition. Int J Clin Pract. 2008;62:810-815. (Pubitemid 351533675)